Clinical Trial Update: Feasibility Study to Assess the Safety and Functionality of the GluSense Continuous Glucose Monitor in Diabetic Patients [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial assessing safety and functionality of the GluSense continuous glucose monitor in diabetic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: GluSense Ltd | Conditions: Diabetes | Phase 1 | Status: COMPLETED